$37.07
At close: Aug 17, 5:00 PM EST
$37.07
N/A
After Hours: Aug 14, 4:00 PM EST
Parabilis Medicines Inc
PBLSNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open
Parabilis Medicines Market Sentiment
Market sentiment signals for Parabilis Medicines (PBLS): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 4.2% short float
Options Flow▲ 0.00 P/C ratio
Insider Activity▲ Net Buyer (30d)
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
0.00
More calls — Bullish
2 calls · 0 puts
Avg Consensus PT
$42
+12.4%
Highest Price Target
$45
+21.4%
B of A Securities
Lowest Price Target
$40
+7.9%
Leerink Partners
Short Interest
4.2%
Rising — Bearish
Insider Activity (30d)
Net Buyer
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Leerink Partners | Andrew Berens— | +7.9% | $40 | Initiate | Outperform |
| Jul 6, 2026 | Guggenheim | Michael Schmidt— | +7.9% | $40 | Initiate | Buy |
